Login to Your Account



Biogen Idec reports a great year an a positive outlook

By Peter Winter
BioWorld Insight Editor

Wednesday, January 29, 2014
In a year that was driven largely by significant growth in its expanded multiple sclerosis (MS) franchise, Cambridge, Mass.-based Biogen Idec Inc. reported $6.9 billion in revenue, a 26 percent increase compared to 2012, in its full year and fourth quarter 2013 financial results released yesterday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription